Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation

DOI: 10.2147/TCRM.S147327

Keywords: kidney transplantation, tacrolimus, HMG-CoA reductase inhibitors, major adverse cardiovascular events (MACE)

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text